12:00 AM
 | 
Apr 18, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

ImmunoGen preclinical data

In mouse xenograft models of ovarian cancer, single IV injections of 2.5 and 5 mg/kg IMGN853 induced complete tumor regression in...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >